Creutzfeldt-Jakob Disease Clinical Trials

Find Creutzfeldt-Jakob Disease Clinical Trials Near You

Expanded Protocol for Teleneurology Assessment Program for Creutzfeldt-Jakob Disease (TAPCJD)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This observational study uses secure videoconference visits to follow people with Creuztzfeldt-Jakob disease (CJD) over time. The study collects information about participants' symptoms, neurological function, thinking and memory, and ability to perform daily activities. It also collects information from study partners about the participant and about their own well-being and experiences as caregivers. The goal of the study is to better understand how CJD changes over time and to evaluate the use of remote assessments for CJD research and surveillance.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Study Participant Inclusion Criteria:

• Age greater than 18 years.

• Participant must have a study partner who will be present with the participant for all videoconference evaluations (in the same physical location).

• Participant meets criteria for definite or probable prion disease or is a known PRNP mutation carrier with active disease.

• Participant and/or appropriate proxy consents to study participation.

⁃ Study Partner Inclusion Criteria:

• Age greater than 18 years.

• Study partner must be present with the participant for all videoconference evaluations and must have knowledge of the participant's abilities before the onset of illness. The study partner should be with the participant at least three times per week or for a total of five hours per week as the illness progresses.

• Study partner must have internet access and a computer, smartphone, or tablet with videoconference capabilities.

• Study partner consents to study participation.

Locations
United States
Ohio
University Hospitals Cleveland Medical Center
RECRUITING
Cleveland
Contact Information
Primary
Brian S Appleby, MD
cjdsurveillance@uhhospitals.org
216-368-0587
Time Frame
Start Date: 2022-01-25
Estimated Completion Date: 2032-01-25
Participants
Target number of participants: 200
Treatments
Prion Disease
Adults with definite or probable prion disease, or known PRNP mutation carriers with active disease, who participate in longitudinal videoconference assessments with a study partner.
Related Therapeutic Areas
Sponsors
Leads: University Hospitals Cleveland Medical Center
Collaborators: Case Western Reserve University, CJD Foundation

This content was sourced from clinicaltrials.gov